F&D

Meyer, an associate of London based multinational Vitabiotics Ltd.,is a rapidly growing Pharma Co. in India. Leading pharmaceutical manufacturer, founded in 1982 .,in technical collaboration with OMEGA-MEYER Ltd Jersey( Br. Isles). H.O. based in THANE

Post: Junior Executive

The Institute of Pharmacy has been established with a view to promote excellence in pharmaceutical education and to prepare young men and women to meet the challenges in the area of pharmaceutical industries, education, research and development and marketing. We aim to provide degree, postgraduate, doctoral and postdoctoral level education at this centre of excellence. The pharmacy profession in Gujarat and western part of India has been striving for such a centre and establishment of IP.

Nectar Lifesciences Ltd (NecLife) is a 200 million US$ integrated pharmaceutical organization, offering comprehensive range of Cephalosporin Active Pharmaceutical Ingredients and Finished Dosage Forms. The development and manufacture of quality intermediates, bulk actives have been critical to our success to become one of the largest manufacturers of cephalosporin range of products and delivering innovative and affordable products to domestic as well as international markets.

BAFNA PHARMACEUTICALS LTD is EU - GMP, UK - MHRA, TGA Australia accredited facility in Non Betalactum solid oral Dosage forms providing consistent and unmatched service by supplying hi-end pharmaceutical formulations to Regulated Market of United Kingdom, Europe and Australia apart from Emerging Markets like Sri Lanka, Africa and CIS countries etc. Currently we manufacture and market over 336 licensed pharmaceutical products across various therapeutic spectrum.

Surya Healthcare is a subsidiary of Surya Pharmaceuticals Limited with widespread domestic and international operations. The force behind Surya Healthcare is its parent company Surya Pharmaceuticals Limited. It is uniquely positioned in the Pharmaceutical trade known for its competencies in API, formulation and contract manufacturing across different therapeutic segments serving both domestic and international clients.

Naprod’s vision is to become a world class player in oncology through excellence in innovation, discovery of new manufacturing processes / drug delivery mechanisms and consistently high quality of production. We commenced operations in 1994 with the inauguration of our ultra-modern facility for the production of generics and formulations for oncology and other therapeutic applications. We are one of the pioneers in India in lyophilization.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.